Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,006 shares at $16.94 ($119K) on 2024-05-02, disclosed to the SEC on 2024-05-03.
Open-market sale of $119k ACAD by EVP, CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.94 | 3,503 | $59K | 50.0% |
| 2 | $16.94 | 3,503 | $59K | 50.0% |
| Total | $16.94 avg | 7,006 | $119K | 100% |
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |